Languages SpokenEnglish Common ConditionsBased on the training and education, Dr. Meghan Heberton, MD may treat patients with the following conditions. Please always check with Dr. Meghan Heberton, MD directly about which exact conditions he treats. Prescribed MedicationsTerbinafine Levothyroxine Fluocinolone Acetonide (Generic Name: fluocinolone/shower cap) Tretinoin Ciclopirox Valacyclovir Methotrexate Research PublicationsApproximately 46% of Dermatologists in Houston, TX have available research publications Introduction to the special issue on oncodermatology. Meghan Heberton JAAD case reports 2025-03-02 Erythema multiforme-like targetoid eruption in two patients treated with capivasertib for metastatic breast cancer. Heejo Keum, Jane L Zhu, Meghan Heberton, Travis Vandergriff, Arturo R Dominguez JAAD case reports 2024-09-12 Imatinib associated discoid lupus erythematosus in a patient with chronic myeloid leukemia. Priya Sarlashkar, Christian Carr, Meghan Heberton JAAD case reports 2024-09-01 Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study. Priya Sarlashkar, Jennifer G Gill, Meghan Heberton Journal of the American Academy of Dermatology 2024-07-05 Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients. Zoha K Momin, Jennifer G Gill, Meghan Heberton Archives of dermatological research 2024-05-31 Clinical Features and Outcomes of Black Patients With Melanoma. Sophia N Wix, Ariel B Brown, Meghan Heberton, Adewole S Adamson, Jennifer G Gill JAMA dermatology 2024-03-01 Tumoral melanosis: A case series of patients with metastatic melanoma after systemic immunotherapy. Sophia N Wix, Meghan Heberton, Travis W Vandergriff, Kim B Yancey, Jennifer G Gill JAAD case reports 2024-01-23 Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. Na Niu, Meghan M Heberton, Zhenya Tang, Phyu P Aung, Priyadharsini Nagarajan, Jonathan L Curry, Victor G Prieto, Carlos A Torres-Cabala, Woo Cheal Cho Journal of cutaneous pathology 2023-03-21 Erratum to "Periorbital edema associated with alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596]. Elizabeth A Dao, Saira J George, Meghan M Heberton, Omar Pacha, Craig A Kovitz, Anisha B Patel, Rhea M Phillips Cancer treatment and research communications 2022-11-30 Durvalumab-associated generalized morphea with overlapping vitiligo. Julianna Martel, Woo Cheal Cho, John S Runge, Anisha B Patel, Jean Tayar, Karin Woodman, Celyne Bueno Hume, Jonathan Curry, Meghan Heberton JAAD case reports 2022-10-13 Payments From Medical Companies(These can include payments from pharmaceutical companies, medical device companies, and other companies.) Dr. Meghan Heberton, MD has received over $2,176 in payments from medical companies (88% less than the average Dermatologist in Houston, TX) - Over $1,863 in payments for Honoraria (15 times the average Dermatologist in Houston, TX)
- Over $313 in payments for Food and Beverage (92% less than the average Dermatologist in Houston, TX)
Blueprint Medicines Corporation - $1,863.00 payment for Honoraria on 03/20/2024 ABBVIE INC. - $19.05 payment for Food and Beverage on 01/05/2024 Bausch Health US, LLC - $77.88 payment for Food and Beverage on 05/10/2022 Galderma Laboratories, L.P. - $106.27 payment for Food and Beverage on 05/23/2019 Novartis Pharmaceuticals Corporation - $110.67 payment for Food and Beverage on 01/16/2018
Affiliated FacilitiesParkland Health and Hospital System Ut Southwestern University Hospital
|